Literature DB >> 34151178

Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant.

Enyia R Anderson1, Grant L Hughes1, Edward I Patterson1,2.   

Abstract

Until an effective vaccine against SARS-CoV-2 is available on a widespread scale, the control of the COVID-19 pandemic is reliant upon effective pandemic control measures. The ability of SARS-CoV-2 to remain viable on surfaces and in aerosols, means indirect contact transmission can occur and there is an opportunity to reduce transmission using effective disinfectants in public and communal spaces. Virusend (TX-10), a novel disinfectant, has been developed as a highly effective disinfectant against a range of microbial agents. Here we investigate the ability of Virusend to inactivate SARS-CoV-2. Using surface and solution inactivation assays, we show that Virusend is able to reduce SARS-CoV-2 viral titre by 4 log10 p.f.u. ml-1 within 1 min of contact. Ensuring disinfectants are highly effective against SARS-CoV-2 is important in eliminating environmental sources of the virus to control the COVID-19 pandemic.
© 2021 The Authors.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; TX-10; Virusend; disinfectant; inactivation

Year:  2021        PMID: 34151178      PMCID: PMC8208756          DOI: 10.1099/acmi.0.000228

Source DB:  PubMed          Journal:  Access Microbiol        ISSN: 2516-8290


  19 in total

1.  The COVID-19 vaccine development landscape.

Authors:  Tung Thanh Le; Zacharias Andreadakis; Arun Kumar; Raúl Gómez Román; Stig Tollefsen; Melanie Saville; Stephen Mayhew
Journal:  Nat Rev Drug Discov       Date:  2020-05       Impact factor: 84.694

2.  Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays.

Authors:  Edward I Patterson; Tessa Prince; Enyia R Anderson; Aitor Casas-Sanchez; Shirley L Smith; Cintia Cansado-Utrilla; Tom Solomon; Michael J Griffiths; Álvaro Acosta-Serrano; Lance Turtle; Grant L Hughes
Journal:  J Infect Dis       Date:  2020-10-01       Impact factor: 5.226

3.  Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong.

Authors:  Shenglan Xiao; Yuguo Li; Tze-Wai Wong; David S C Hui
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

4.  Ensuring global access to COVID-19 vaccines.

Authors:  Gavin Yamey; Marco Schäferhoff; Richard Hatchett; Muhammad Pate; Feng Zhao; Kaci Kennedy McDade
Journal:  Lancet       Date:  2020-03-31       Impact factor: 79.321

Review 5.  The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world.

Authors:  Hannah R Sharpe; Ciaran Gilbride; Elizabeth Allen; Sandra Belij-Rammerstorfer; Cameron Bissett; Katie Ewer; Teresa Lambe
Journal:  Immunology       Date:  2020-07       Impact factor: 7.397

6.  The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2.

Authors:  Vincent Chi-Chung Cheng; Shuk-Ching Wong; Vivien Wai-Man Chuang; Simon Yung-Chun So; Jonathan Hon-Kwan Chen; Siddharth Sridhar; Kelvin Kai-Wang To; Jasper Fuk-Woo Chan; Ivan Fan-Ngai Hung; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  J Infect       Date:  2020-04-23       Impact factor: 6.072

7.  SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19 ward of a hospital in Milan, Italy.

Authors:  Katia Razzini; Marta Castrica; Laura Menchetti; Lorenzo Maggi; Lucia Negroni; Nicola V Orfeo; Alice Pizzoccheri; Matteo Stocco; Stefano Muttini; Claudia M Balzaretti
Journal:  Sci Total Environ       Date:  2020-06-26       Impact factor: 10.753

8.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

9.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.

Authors:  Joel Hellewell; Sam Abbott; Amy Gimma; Nikos I Bosse; Christopher I Jarvis; Timothy W Russell; James D Munday; Adam J Kucharski; W John Edmunds; Sebastian Funk; Rosalind M Eggo
Journal:  Lancet Glob Health       Date:  2020-02-28       Impact factor: 26.763

10.  Variation in microparasite free-living survival and indirect transmission can modulate the intensity of emerging outbreaks.

Authors:  C Brandon Ogbunugafor; Miles D Miller-Dickson; Victor A Meszaros; Lourdes M Gomez; Anarina L Murillo; Samuel V Scarpino
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

View more
  4 in total

1.  CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.

Authors:  Enyia R Anderson; Edward I Patterson; Siobhan Richards; Ana K Pitol; Thomas Edwards; Dominic Wooding; Kate Buist; Alison Green; Sayandip Mukherjee; Michael Hoptroff; Grant L Hughes
Journal:  J Med Microbiol       Date:  2022-02       Impact factor: 2.472

Review 2.  The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment.

Authors:  Kuldeep Dhama; Shailesh Kumar Patel; Rakesh Kumar; Rupali Masand; Jigyasa Rana; Mohd Iqbal Yatoo; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Senthilkumar Natesan; Manish Dhawan; Tauseef Ahmad; Talha Bin Emran; Yashpal Singh Malik; Harapan Harapan
Journal:  Environ Sci Pollut Res Int       Date:  2021-05-15       Impact factor: 4.223

Review 3.  Disinfection methods against SARS-CoV-2: a systematic review.

Authors:  C P Viana Martins; C S F Xavier; L Cobrado
Journal:  J Hosp Infect       Date:  2021-10-18       Impact factor: 8.944

Review 4.  Disinfectants against SARS-CoV-2: A Review.

Authors:  Shuqi Xiao; Zhiming Yuan; Yi Huang
Journal:  Viruses       Date:  2022-08-04       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.